ArticleFrontiers in oncology2022

Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the Combination.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.